PT2404593T - Composição que contém compostos de amónio quaternário - Google Patents

Composição que contém compostos de amónio quaternário

Info

Publication number
PT2404593T
PT2404593T PT111650115T PT11165011T PT2404593T PT 2404593 T PT2404593 T PT 2404593T PT 111650115 T PT111650115 T PT 111650115T PT 11165011 T PT11165011 T PT 11165011T PT 2404593 T PT2404593 T PT 2404593T
Authority
PT
Portugal
Prior art keywords
composition containing
quaternary ammonium
ammonium compounds
containing quaternary
compounds
Prior art date
Application number
PT111650115T
Other languages
English (en)
Inventor
Rabinovich-Guilatt Laura
Lambert Grégory
Lallemand Frédéric
Philips Betty
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/494,493 external-priority patent/US20080026013A1/en
Priority claimed from EP06291236.5A external-priority patent/EP1891939B1/en
Application filed by Santen Sas filed Critical Santen Sas
Publication of PT2404593T publication Critical patent/PT2404593T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT111650115T 2006-07-28 2007-07-27 Composição que contém compostos de amónio quaternário PT2404593T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/494,493 US20080026013A1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP06291236.5A EP1891939B1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP07112097 2007-07-09
PCT/IB2007/053441 WO2008035246A2 (en) 2006-07-28 2007-07-10 Compositions containing quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
PT2404593T true PT2404593T (pt) 2016-08-16

Family

ID=65014357

Family Applications (2)

Application Number Title Priority Date Filing Date
PT77879989T PT2049079T (pt) 2006-07-28 2007-07-27 Composições que contêm compostos de amónio quaternários
PT111650115T PT2404593T (pt) 2006-07-28 2007-07-27 Composição que contém compostos de amónio quaternário

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT77879989T PT2049079T (pt) 2006-07-28 2007-07-27 Composições que contêm compostos de amónio quaternários

Country Status (18)

Country Link
US (7) US7973081B2 (pt)
EP (2) EP2049079B1 (pt)
JP (1) JP5441058B2 (pt)
KR (2) KR101507097B1 (pt)
AU (1) AU2007278141B2 (pt)
CA (1) CA2659322C (pt)
CY (3) CY1118148T1 (pt)
DK (2) DK2049079T3 (pt)
ES (2) ES2606467T3 (pt)
HK (1) HK1165993A1 (pt)
HU (2) HUE030841T2 (pt)
IL (2) IL196740A (pt)
LT (2) LT2049079T (pt)
LU (1) LUC00006I2 (pt)
PL (2) PL2404593T3 (pt)
PT (2) PT2049079T (pt)
SI (2) SI2404593T1 (pt)
WO (2) WO2008035246A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
AU2009260572B2 (en) * 2008-05-28 2015-07-23 Alcon Research, Ltd. Self-preserved emulsions
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2228057A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
WO2010127231A2 (en) * 2009-05-01 2010-11-04 Signal Investment And Management Co. Moisturizing antimicrobial composition
NZ596932A (en) 2009-06-05 2014-04-30 Allergan Inc Artificial tears and therapeutic uses
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2013098841A1 (en) * 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
US9314528B2 (en) * 2011-12-07 2016-04-19 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
US20160074178A1 (en) * 2014-09-17 2016-03-17 Van Phillips METHODS FOR PREPARING PRECISELY FITTED CASTS for PROSTHETICS
EP3011959A1 (en) * 2014-10-23 2016-04-27 Santen SAS Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha
MX2017006474A (es) 2014-11-25 2017-09-12 Allergan Inc Composiciones oftalmicas estabilizadas de omega 3.
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
RS58292B1 (sr) * 2016-07-07 2019-03-29 Salvat Lab Sa Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida
EP3970692A1 (en) * 2020-09-18 2022-03-23 Omnivision GmbH Lipid-based ophthalmic composition for the treatment of dry eye
JP2023548966A (ja) 2020-11-09 2023-11-21 スカイ・セラピューティクス・カンパニー・リミテッド 固相のシクロスポリンａ及びこれを含む分散組成物
US11471475B1 (en) * 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
WO2024069490A1 (en) * 2022-09-28 2024-04-04 Polaroid Ip B.V. Antimicrobial coating compositions

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB633175A (en) * 1946-09-03 1949-12-12 Parke Davis & Co Antibiotic preparations and process for obtaining the same
USB724600I5 (pt) * 1968-04-26
AU499860B2 (en) 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2648462B1 (fr) 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JPH05116286A (ja) 1991-10-25 1993-05-14 Matsushita Electric Ind Co Ltd インク吐出装置
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
IL103907A0 (en) * 1992-11-27 1993-04-04 Pharmos Corp Ophthalmic compositions
DE69328368T2 (de) 1992-08-28 2000-08-10 Pharmos Corp Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
EP0631770B1 (en) 1993-06-25 1998-07-22 Alcon Cusi, S.A. New use of polymeric membranes in the dispensing of pharmaceutical solutions that contain quaternary ammonium compounds as preservatives and corresponding dose dispensor
NO943200L (no) * 1993-08-30 1995-03-01 Curtis Helene Ind Inc Sjampokondisjoneringspreparat
US5547990A (en) * 1994-05-20 1996-08-20 Lonza, Inc. Disinfectants and sanitizers with reduced eye irritation potential
EP0760650B1 (en) * 1994-05-20 2002-07-31 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5767153A (en) 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
TW446563B (en) * 1996-01-16 2001-07-21 Colgate Palmolive Co Low static conditioning shampoo
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
US6114319A (en) 1997-05-14 2000-09-05 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
US20020169138A1 (en) * 1997-10-24 2002-11-14 Southern Research Institute Delivery vehicles for bioactive agents and uses thereof
WO1999051763A1 (en) 1998-04-02 1999-10-14 The Schepens Eye Research Institute, Inc. Corneal organ culture system for chemical toxicity tests of consumer products
FR2780879B1 (fr) * 1998-07-09 2002-09-20 Oreal Composition cosmetique photoprotectrice contenant un tensio-actif anionique, un compose filtrant le rayonnement ultraviolet et un compose cationique ou zwitterionique amphiphile et son utilisation
BR9913955A (pt) * 1998-09-25 2001-06-12 Alcon Lab Inc Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
US6030789A (en) 1999-03-10 2000-02-29 The Gillette Company Human conjunctival epithelial cell lines with an extended life span
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
AU776609B2 (en) * 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
DK1142566T3 (da) 2000-04-07 2004-02-09 Medidom Lab Oftalmologiske formuleringer på basis af ciclosporin, hyaluronsyre og polysorbat
AU2002314847A1 (en) * 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
WO2004030608A2 (en) 2001-06-05 2004-04-15 The Regents Of The University Of Michigan Nanoemulsion vaccines
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
AU2002214233A1 (en) 2001-11-01 2003-07-09 Novagali Pharma Sa Method and composition for dry eye treatment
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
EP1490030B2 (en) 2002-03-20 2010-07-14 Elan Pharma International Limited Nanoparticulate compositions of angiogenesis inhibitors
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
US20050175651A1 (en) 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US20050158349A1 (en) 2004-01-20 2005-07-21 Jampani Hanuman B. Two-phase compositions containing alcohol
ATE439123T1 (de) 2004-07-02 2009-08-15 Novagali Pharma Sa Verwendung von emulsionen zur intra- und periocularen injection
DE602004017477D1 (de) 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
AU2005304034B2 (en) 2004-11-09 2012-02-16 Santen Sas Ophthalmic emulsions containing an immunosuppressive agent
MX2008009605A (es) 2006-01-30 2008-12-19 Titan Pharmaceuticals Inc Uso del galio para tratar infecciones asociadas con una biopelicula.
US20080026013A1 (en) 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20090018057A1 (en) * 2007-07-09 2009-01-15 Gregory Lambert OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES

Also Published As

Publication number Publication date
ES2606467T3 (es) 2017-03-24
HUE029987T2 (en) 2017-04-28
KR101507465B1 (ko) 2015-03-31
US11612658B2 (en) 2023-03-28
US7973081B2 (en) 2011-07-05
AU2007278141A1 (en) 2008-01-31
PL2049079T3 (pl) 2017-03-31
US10842873B2 (en) 2020-11-24
WO2008012367A3 (en) 2008-05-29
WO2008035246A2 (en) 2008-03-27
KR20140041845A (ko) 2014-04-04
LTC2049079I2 (lt) 2019-12-27
IL241753A0 (en) 2015-11-30
US20210038721A1 (en) 2021-02-11
KR101507097B1 (ko) 2015-03-31
ES2586381T3 (es) 2016-10-14
IL196740A (en) 2015-10-29
JP2009544667A (ja) 2009-12-17
HUE030841T2 (en) 2017-06-28
WO2008035246A3 (en) 2008-06-26
IL196740A0 (en) 2009-11-18
US9220694B2 (en) 2015-12-29
EP2404593A1 (en) 2012-01-11
DK2049079T3 (da) 2017-01-02
WO2008012367A2 (en) 2008-01-31
LUC00006I2 (pt) 2017-05-02
HK1165993A1 (zh) 2012-10-19
CA2659322C (en) 2014-07-15
DK2404593T3 (en) 2016-08-29
SI2404593T1 (sl) 2016-11-30
EP2049079B1 (en) 2016-09-07
SI2049079T1 (sl) 2017-03-31
JP5441058B2 (ja) 2014-03-12
CY1118148T1 (el) 2017-06-28
LUC00006I1 (pt) 2017-02-28
CY2017007I1 (el) 2017-06-28
US20130337019A1 (en) 2013-12-19
US20230181738A1 (en) 2023-06-15
PL2404593T3 (pl) 2016-11-30
CA2659322A1 (en) 2008-01-31
US20190022231A1 (en) 2019-01-24
EP2404593B1 (en) 2016-05-11
IL241753B (en) 2018-03-29
US20110201689A1 (en) 2011-08-18
EP2049079A2 (en) 2009-04-22
LTPA2017003I1 (lt) 2017-03-10
US20160082107A1 (en) 2016-03-24
LT2049079T (lt) 2016-12-12
US20200000924A9 (en) 2020-01-02
CY1118436T1 (el) 2017-06-28
US8524779B2 (en) 2013-09-03
KR20090047496A (ko) 2009-05-12
US20080026991A1 (en) 2008-01-31
CY2017007I2 (el) 2017-06-28
US9956289B2 (en) 2018-05-01
PT2049079T (pt) 2016-12-09
AU2007278141B2 (en) 2014-01-16

Similar Documents

Publication Publication Date Title
IL241753A0 (en) Preparations containing quaternary ammonium compounds
HUS1700007I1 (hu) Kvaterner ammónium vegyületeket tartalmazó készítmények
HUS1900033I1 (hu) Szubsztituált enaminokarbonil vegyületek
IL185312A0 (en) Compositions containing aptamers
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
IL190321A0 (en) Compositions containing saratin
EP1984379A4 (en) ANTI-ARENAVIRAL COMPOUNDS
GB2436469B (en) Quaternary ammonium compounds and their uses
HK1112409A1 (en) Compositions containing quaternary ammonium compounds
PL2190800T3 (pl) Mieszanka zawierająca czwartorzędowy związek amoniowy i jej zastosowanie
EP2082022A4 (en) COMPOUNDS
EP2004174A4 (en) NAPHTHALENEDIONED COMPOUNDS
GB0602042D0 (en) Compounds
SG10201601998PA (en) Compositions containing lignan-class compounds
EP1973905A4 (en) COMPOUNDS
ZA200901570B (en) Substituted azolin-2-YL-amino compounds
EP2016069A4 (en) BISPYRIDINIUMVERBINDUNGEN
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0600929D0 (en) Compounds
GB0601612D0 (en) Compounds
GB0600426D0 (en) Compounds
GB0601505D0 (en) Compounds
GB0602040D0 (en) Compounds